Jade Biosciences, Inc. Basic Shares Outstanding (Weighted Average)
Jade Biosciences, Inc. (JBIO) reported Basic Shares Outstanding (Weighted Average) of 61.05 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 61.05M shares, a 114.73% increase year-over-year.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 57.78M shares, a 1731.00% increase year-over-year.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 53.99M shares, a 1610.98% increase year-over-year.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 39.58M shares, a 1154.46% increase year-over-year.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 31.36M shares, a 9.72% increase from fiscal 2024.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 28.58M shares, a 8.55% increase from fiscal 2023.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 26.33M shares, a 7.60% increase from fiscal 2022.
- Jade Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 24.47M shares, a 99.06% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 0 month | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 61.05M shares 10-Q · filed 2026-08-10 | 59.42M shares 10-Q · filed 2026-08-10 | 57.61M shares derived: average of 3 quarters · filed 2026-08-10 | 53.10M shares derived: average of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | 57.78M shares 10-Q · filed 2026-05-07 | 55.88M shares derived: average of 2 quarters · filed 2026-05-07 | 50.45M shares derived: average of 3 quarters · filed 2026-05-07 | 44.95M shares derived: average of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | 53.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 46.79M shares derived: average of 2 quarters · filed 2026-03-06 | 40.67M shares derived: average of 3 quarters · filed 2026-08-10 | 31.36M shares 10-K · filed 2026-03-06 | ||
| 2025-09-30 | 39.58M shares 10-Q · filed 2025-11-14 | 34.01M shares derived: average of 2 quarters · filed 2026-08-10 | 23.82M shares 10-Q · filed 2025-11-14 | 18.58M shares derived: average of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | 28.43M shares 10-Q · filed 2026-08-10 | 15.93M shares 10-Q · filed 2026-08-10 | 11.58M shares derived: average of 3 quarters · filed 2026-08-10 | 9.47M shares derived: average of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | 3.16M shares 10-Q · filed 2026-05-07 | 28.99M shares 10-Q · filed 2025-04-25 | 3.16M shares derived: average of 2 quarters · filed 2026-05-07 | 3.16M shares derived: average of 3 quarters · filed 2026-05-07 | 9.56M shares derived: average of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | 3.16M shares derived: 10-K 6 month − 10-Q 3 month · filed 2026-03-06 | 3.16M shares 10-K · filed 2026-03-06 | 11.69M shares derived: average of 3 quarters · filed 2026-03-06 | 28.58M shares 10-K · filed 2025-03-27 | ||
| 2024-09-30 | 3.16M shares 10-Q · filed 2025-11-14 | 28.86M shares 10-Q · filed 2024-11-12 | 15.96M shares derived: average of 2 quarters · filed 2025-11-14 | 28.57M shares 10-Q · filed 2024-11-12 | 21.85M shares derived: average of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | 3.16M shares 10-Q · filed 2025-08-13 | 28.76M shares 10-Q · filed 2024-08-12 | 28.57M shares 10-Q · filed 2024-08-12 | 28.09M shares derived: average of 3 quarters · filed 2025-04-25 | 27.98M shares derived: average of 4 quarters · filed 2025-04-25 | |
| 2024-03-31 | 27.80M shares 10-Q · filed 2025-04-25 | 27.75M shares derived: average of 2 quarters · filed 2025-04-25 | 27.72M shares derived: average of 3 quarters · filed 2025-04-25 | 27.08M shares derived: average of 4 quarters · filed 2025-04-25 | ||
| 2023-12-31 | 27.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 27.68M shares derived: average of 2 quarters · filed 2025-03-27 | 26.84M shares derived: average of 3 quarters · filed 2025-03-27 | 26.33M shares 10-K · filed 2025-03-27 | ||
| 2023-09-30 | 27.64M shares 10-Q · filed 2024-11-12 | 26.40M shares derived: average of 2 quarters · filed 2024-11-12 | 25.87M shares 10-Q · filed 2024-11-12 | 25.55M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 25.17M shares 10-Q · filed 2024-08-12 | 24.97M shares 10-Q · filed 2024-08-12 | 24.85M shares derived: average of 3 quarters · filed 2024-08-12 | 24.75M shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 24.78M shares 10-Q · filed 2024-05-13 | 24.70M shares derived: average of 2 quarters · filed 2024-05-13 | 24.61M shares derived: average of 3 quarters · filed 2024-05-13 | 24.56M shares derived: average of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | 24.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 24.53M shares derived: average of 2 quarters · filed 2024-03-25 | 24.49M shares derived: average of 3 quarters · filed 2024-03-25 | 24.47M shares 10-K · filed 2024-03-25 | ||
| 2022-09-30 | 24.45M shares 10-Q · filed 2023-11-13 | 24.43M shares derived: average of 2 quarters · filed 2023-11-13 | 24.43M shares 10-Q · filed 2023-11-13 | 24.48M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 24.41M shares 10-Q · filed 2023-08-14 | 24.41M shares 10-Q · filed 2023-08-14 | 24.48M shares derived: average of 3 quarters · filed 2023-08-14 | 24.33M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 24.41M shares 10-Q · filed 2023-05-15 | 24.52M shares derived: average of 2 quarters · filed 2023-05-15 | 24.31M shares derived: average of 3 quarters · filed 2023-05-15 | 18.29M shares derived: average of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | 24.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 24.26M shares derived: average of 2 quarters · filed 2023-03-29 | 16.25M shares derived: average of 3 quarters · filed 2023-03-29 | 12.29M shares 10-K · filed 2023-03-29 | ||
| 2021-09-30 | 23.89M shares 10-Q · filed 2022-11-14 | 12.06M shares derived: average of 2 quarters · filed 2022-11-14 | 8.18M shares 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | 243.08K shares 10-Q · filed 2022-08-15 | 243.08K shares 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | 243.08K shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |